ATN 064: IMMUNOGENICITY, SAFETY, TOLERABILITY, AND BEHAVIORAL CONSEQUENCES OF

ATN 064：免疫原性、安全性、耐受性和行为后果

• 批准号: 8167298
• 负责人: LAWRENCE James D'ANGELO
• 金额: $ 0.63万
• 依托单位: CHILDREN'S RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-01-20 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8167298
• 关键词: Behavioral; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Human Papilloma Virus Vaccine; Institution; Phase; Research; Research Personnel; Resources; Safety; Source; United States National Institutes of Health; Vaccination; Woman; immunogenic; immunogenicity; open label; risk perception; sex risk

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objectives of this phase II, open-label, multi-center study are to determine whether the quadrivalent HPV vaccine is immunogenic, safe, and well-tolerated in 16- to 23-year-old HIV-infected young women, and to examine whether vaccination impacts their perceptions of risk and sexual behaviors.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 这项 II 期、开放标签、多中心研究的目的是确定四价 HPV 疫苗对于 16 至 23 岁感染 HIV 的年轻女性是否具有免疫原性、安全性和耐受性良好，并检查疫苗接种是否会影响他们对风险和性行为的看法。